Asset Details
MbrlCatalogueTitleDetail
Do you wish to reserve the book?
Controversies in Assessment, Diagnosis, and Treatment of Kratom Use Disorder
by
Smith, Kirsten E.
, Epstein, David H.
, Weiss, Stephanie T.
in
Addictions
/ Diagnostic and Statistical Manual of Mental Disorders
/ Drug use
/ Drug withdrawal
/ Humans
/ Medicine
/ Medicine & Public Health
/ Mental disorders
/ Mitragyna - adverse effects
/ Opiate Substitution Treatment - methods
/ Opioid-Related Disorders - diagnosis
/ Opioid-Related Disorders - drug therapy
/ Patients
/ Psychiatry
/ Review
/ Substance abuse treatment
/ Substance use disorder
/ Substance-Related Disorders - diagnosis
/ Substance-Related Disorders - drug therapy
/ Substance-Related Disorders - therapy
/ Topical Collection on Substance Use and Related Disorders
2024
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Controversies in Assessment, Diagnosis, and Treatment of Kratom Use Disorder
by
Smith, Kirsten E.
, Epstein, David H.
, Weiss, Stephanie T.
in
Addictions
/ Diagnostic and Statistical Manual of Mental Disorders
/ Drug use
/ Drug withdrawal
/ Humans
/ Medicine
/ Medicine & Public Health
/ Mental disorders
/ Mitragyna - adverse effects
/ Opiate Substitution Treatment - methods
/ Opioid-Related Disorders - diagnosis
/ Opioid-Related Disorders - drug therapy
/ Patients
/ Psychiatry
/ Review
/ Substance abuse treatment
/ Substance use disorder
/ Substance-Related Disorders - diagnosis
/ Substance-Related Disorders - drug therapy
/ Substance-Related Disorders - therapy
/ Topical Collection on Substance Use and Related Disorders
2024
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
Controversies in Assessment, Diagnosis, and Treatment of Kratom Use Disorder
by
Smith, Kirsten E.
, Epstein, David H.
, Weiss, Stephanie T.
in
Addictions
/ Diagnostic and Statistical Manual of Mental Disorders
/ Drug use
/ Drug withdrawal
/ Humans
/ Medicine
/ Medicine & Public Health
/ Mental disorders
/ Mitragyna - adverse effects
/ Opiate Substitution Treatment - methods
/ Opioid-Related Disorders - diagnosis
/ Opioid-Related Disorders - drug therapy
/ Patients
/ Psychiatry
/ Review
/ Substance abuse treatment
/ Substance use disorder
/ Substance-Related Disorders - diagnosis
/ Substance-Related Disorders - drug therapy
/ Substance-Related Disorders - therapy
/ Topical Collection on Substance Use and Related Disorders
2024
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Controversies in Assessment, Diagnosis, and Treatment of Kratom Use Disorder
Journal Article
Controversies in Assessment, Diagnosis, and Treatment of Kratom Use Disorder
2024
Request Book From Autostore
and Choose the Collection Method
Overview
Purpose of Review
We apply the Diagnostic and Statistical Manual of Mental Disorders Fifth Edition (DSM-5) criteria for substance use disorders (SUDs) to the herbal product kratom. Similarities and differences between kratom use disorder (KUD) and other SUDs are explored, along with assessment, diagnostic, and therapeutic recommendations for KUD.
Recent Findings
Literature reports of “kratom addiction” or KUD rarely specify the criteria by which patients were diagnosed. Individuals meeting DSM-5 KUD criteria typically do so via tolerance and withdrawal, using more than intended, and craving, not functional or psychosocial disruption, which occur rarely. Most clinicians who use medication to treat patients with isolated KUD select buprenorphine formulations, although there are no controlled studies showing that buprenorphine is safe or efficacious in this patient population.
Summary
Diagnosis and treatment decisions for KUD should be systematic. We propose an algorithm that takes into consideration whether KUD occurs with comorbid opioid use disorder.
Publisher
Springer US,Springer Nature B.V
Subject
/ Diagnostic and Statistical Manual of Mental Disorders
/ Drug use
/ Humans
/ Medicine
/ Opiate Substitution Treatment - methods
/ Opioid-Related Disorders - diagnosis
/ Opioid-Related Disorders - drug therapy
/ Patients
/ Review
/ Substance-Related Disorders - diagnosis
/ Substance-Related Disorders - drug therapy
This website uses cookies to ensure you get the best experience on our website.